Aditxt, Inc. (ADTX): Total Liabilities
$12.56M
As of 2025-12-31
$49.08M
As of 2026-03-31
+31.5%
3-year compound annual growth
+43.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.56M | -47.3% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $23.86M | -16.4% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $28.53M | +416.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $5.53M | -14.7% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $6.48M | +210.9% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $2.09M | -29.9% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $2.98M | n/a | 2021-03-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | 2025-12-31 | $12.56M | -47.3% |
| One World Products, Inc. (OWPC) | 2024-12-31 | $5.26M | +35.7% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $813.0K | +17.5% |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $7.69M | +355.5% |
| Genelux Corp (GNLX) | 2025-12-31 | $7.48M | -11.4% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $2.36M | +36.5% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $10.39M | +10.8% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
Compare ADTX, OWPC, TCRT, ASBP side by side · Screen every company in Pharmaceutical Preparations ↗